Invention Grant
US08796305B2 Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
有权
羧基取代的咪唑并[1,2-a]吡啶甲酰胺及其用途
- Patent Title: Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
- Patent Title (中): 羧基取代的咪唑并[1,2-a]吡啶甲酰胺及其用途
-
Application No.: US13789414Application Date: 2013-03-07
-
Publication No.: US08796305B2Publication Date: 2014-08-05
- Inventor: Alexandros Vakalopoulos , Ingo Hartung , Markus Follman , Rolf Jautelat , Niels Lindner , Dirk Schneider , Frank Wunder , Johannes-Peter Stasch , Gorden Redlich , Volkhart Min-Jian Li
- Applicant: Bayer Pharma Aktiengesellschaft
- Applicant Address: DE Berlin
- Assignee: Bayer Pharma Aktiengesellschaft
- Current Assignee: Bayer Pharma Aktiengesellschaft
- Current Assignee Address: DE Berlin
- Agent Karen B. King
- Priority: EP12191202 20121105
- Main IPC: C07D401/10
- IPC: C07D401/10 ; C07D401/02 ; A61K31/4353
![Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use](/abs-image/US/2014/08/05/US08796305B2/abs.jpg.150x150.jpg)
Abstract:
The present application relates to novel substituted imidazo[1,2-a]pyridine-3-carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
Public/Granted literature
- US20140128425A1 Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use Public/Granted day:2014-05-08
Information query